🔥🐔 BizChicken 🐔🔥
Learn About the Corporations Around You
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Eliem Therapeutics, Inc.

Market Cap: Medium
Employees: Lowest
ETX-810, ETX-155, Kv7 Program, Anxiolytic
Eliem Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing therapies for neuronal excitability disorders, including chronic pain and neuropsychiatry. Key products include ETX-810 in Phase IIa for chronic pain, and ETX-155 in Phase I for major depressive disorder.
Symbol: ELYM
Recent Price: $5.11
Industry: Biotechnology
CEO: Dr. Aoife M. Brennan BAO, BCh, M.D., MB, MMSc
Sector: Healthcare
Employees: 9
Address: 23515 NE Novelty Hill Road, Redmond, WA 98053
Phone: 425 276 2300
Last updated: 2024-12-31